Cancer Research UK logo.
SearchDonate
  • Search

A study looking at giving olaparib with chemoradiotherapy for head and neck cancer (ORCA-2)

Overview

Cancer types:

Head and neck cancers

Status:

Closed

Phase:

Phase 1

Details

This study is looking at whether giving olaparib with chemoradiotherapy makes this treatment work better. It is for people with squamous cell cancer of their head and neck that is locally advanced. This study is supported by Cancer Research UK.

Recruitment start: 28 September 2015

Recruitment end: 31 December 2019

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr. Martin Forster

Supported by

Astra Zeneca

Cancer Research UK

Experimental Cancer Medicine Centre (ECMC)

University College London

Other information

This is Cancer Research UK trial number CRUK/D/14/011.

Last reviewed: 7 January 2020

CRUK internal database number: 12211

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.